NASDAQ: CLMT
Calumet Inc Stock

$59.05+1.04 (+1.79%)
Updated Sep 17, 2026
CLMT Price
$59.05
Fair Value Price
-$27.12
Market Cap
$5.19B
52 Week Low
$17.42
52 Week High
$59.30
P/E
-38.1x
P/B
-4.56x
P/S
0.69x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.59B
Earnings
-$136.80M
Gross Margin
6.6%
Operating Margin
-1.4%
Profit Margin
-3%
Debt to Equity
-3.24
Operating Cash Flow
$146M
Beta
0.87
Next Earnings
Nov 6, 2026
Ex-Dividend
N/A
Next Dividend
N/A

CLMT Overview

Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general and administrative expenses not allocated to other segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLMT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Oil and Gas

Industry Rating
B
CLMT
Ranked
#46 of 71

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$12.65A
$23.20A
$17.15A
View Top Oil and Gas Stocks

Be the first to know about important CLMT news, forecast changes, insider trades & much more!

CLMT News

Overview

Due Diligence Score

Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLMT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLMT ($59.05) is overvalued by 317.74% relative to our estimate of its Fair Value price of -$27.12 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLMT ($59.05) is not significantly undervalued (317.74%) relative to our estimate of its Fair Value price of -$27.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLMT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLMT due diligence checks available for Premium users.

Valuation

CLMT fair value

Fair Value of CLMT stock based on Discounted Cash Flow (DCF)

Price
$59.05
Fair Value
-$27.12
Undervalued by
317.74%
CLMT ($59.05) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLMT ($59.05) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLMT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLMT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-38.1x
Industry
15x
Market
45.05x

CLMT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-4.56x
Industry
1.8x

CLMT's financial health

Profit margin

Revenue
$1.4B
Net Income
-$95.9M
Profit Margin
-6.6%
CLMT's Earnings (EBIT) of -$64.50M... subscribe to Premium to read more.
Interest Coverage Financials
CLMT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.8B
Liabilities
$3.7B
Debt to equity
-3.24
CLMT's short-term liabilities ($1.22B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLMT's long-term liabilities ($2.47B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLMT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLMT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$92.3M
Investing
-$39.3M
Financing
-$81.8M
CLMT's operating cash flow ($146.10M)... subscribe to Premium to read more.
Debt Coverage Financials

CLMT vs Oil and Gas Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLMTC$5.19B+1.79%-38.10x-4.56x
MURC$5.40B-1.31%18.30x1.03x
CNXC$4.96B-0.56%5.00x1.02x
CRCC$4.83B-0.09%-41.86x1.42x
CRGYA$4.66B-2.01%128.27x0.90x

Calumet Stock FAQ

What is Calumet's quote symbol?

(NASDAQ: CLMT) Calumet trades on the NASDAQ under the ticker symbol CLMT. Calumet stock quotes can also be displayed as NASDAQ: CLMT.

If you're new to stock investing, here's how to buy Calumet stock.

What is the 52 week high and low for Calumet (NASDAQ: CLMT)?

(NASDAQ: CLMT) Calumet's 52-week high was $59.30, and its 52-week low was $17.42. It is currently -0.41% from its 52-week high and 238.98% from its 52-week low.

How much is Calumet stock worth today?

(NASDAQ: CLMT) Calumet currently has 87,898,234 outstanding shares. With Calumet stock trading at $59.05 per share, the total value of Calumet stock (market capitalization) is $5.19B.

Calumet stock was originally listed at a price of $21.75 in Jan 26, 2006. If you had invested in Calumet stock at $21.75, your return over the last 20 years would have been 171.49%, for an annualized return of 5.12% (not including any dividends or dividend reinvestments).

How much is Calumet's stock price per share?

(NASDAQ: CLMT) Calumet stock price per share is $59.05 today (as of Sep 17, 2026).

What is Calumet's Market Cap?

(NASDAQ: CLMT) Calumet's market cap is $5.19B, as of Sep 18, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Calumet's market cap is calculated by multiplying CLMT's current stock price of $59.05 by CLMT's total outstanding shares of 87,898,234.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.